Medtech
Collaboration aims to enhance efficiency and improve cell quality in primary T-cell culture processes....Read more
10th February, 2025
Offered advanced screenings throughout February to support early detection and prevention of heart disease....Read more
10th February, 2025
The discussion highlights ExacTcell™ Technology’s potential in advancing scalable solutions for medical preparedness....Read more
10th February, 2025
The recommended cash offer to Abliva shareholders is now unconditional, with an extended acceptance period....Read more
10th February, 2025
Enhancing patient-centric care with advanced digital tools and analytics. ...Read more
07th February, 2025
The world’s longest-lasting continuous glucose monitor moves closer to European market approval. ...Read more
07th February, 2025
The collaboration aims to drive long-term brain monitoring and neurostimulation innovations into clinical applications....Read more
06th February, 2025
Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation ...Read more
06th February, 2025
With a strategic separation, BD is creating a pure-play MedTech leader and a focused Life Sciences and Diagnostics entity, driving enhanced investment, innovation, and market impact....Read more
06th February, 2025 | By Ankit Kankar | ankit.kankar@mmactiv.com
The collaboration aims to promote virtual reality solutions for enhancing senior care and well-being....Read more
05th February, 2025
Medtech Special
Artificial Intelligence Breakthroughs
Robots In Medtech
Asia Pacific
Global / International
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer